Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Russell Skibsted currently holds 10,758 shares of AEOLUS PHARMACEUTICALS, INC. (AOLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Russell Skibsted has been a net buyer of AOLS stock. They have purchased $27.2K and sold $0 worth of shares.
Russell Skibsted's most recent insider trade was on May 29, 2026, when they purchased 2,292 shares at $2.57 per share.
Russell Skibsted serves as Executive at AEOLUS PHARMACEUTICALS, INC. (AOLS). They have executed 14 insider transactions totaling $27.2K over their tenure at the company.
Russell Skibsted holds the position of Executive at AEOLUS PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Russell Skibsted has shown a buying trading pattern, with $27.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Russell Skibsted was on Oct 4, 2018, when they sold $8.6K worth of BTX shares. This transaction involved 3,891 shares at $2.22 per share.
Russell Skibsted currently owns 10,758 shares of AEOLUS PHARMACEUTICALS, INC. (AOLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Russell Skibsted's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Russell Skibsted has 14 Form 4 filings on record as an insider at AEOLUS PHARMACEUTICALS, INC..
Set alerts for Russell Skibsted and 40,000+ other insiders.